Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
作者信息
Yu Q S, Atack J R, Rapoport S I, Brossi A
机构信息
Medicinal Chemistry Section, NIDDK, Bethesda, MD 20892.
出版信息
FEBS Lett. 1988 Jul 4;234(1):127-30. doi: 10.1016/0014-5793(88)81317-6.
PMID:3391264
Abstract
Reaction of (-)-eseroline (1) with alkyl, aryl and aralkylisocyanates afforded a series of carbamate analogues of (-)-physostigmine (2) which were assayed for inhibition of acetyl- and butyrylcholinesterase (AChE and BChE, respectively) in vitro. Included in this study were two N-alkyl-substituted carbamates 9 and 14 obtained from (-)-eseroline (1) with dialkylcarbamoyl chlorides, and allophanates 12 and 13 obtained as by-products in the reaction of 1 and benzylcarbamoyl eseroline (8) with benzyl isocyanate. Whereas none of the analogues studied was more potent than 2 against electric eel AChE, and carbamates 6, 7 and 8 were all more than 3 times more potent against human plasma BChE than 2.
摘要
相似文献
1
Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
FEBS Lett. 1988 Jul 4;234(1):127-30. doi: 10.1016/0014-5793(88)81317-6.
2
Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
J Pharmacol Exp Ther. 1989 Apr;249(1):194-202.
3
Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine.（-）-N1-去毒扁豆碱、（-）-依色林及其他（-）-毒扁豆碱的N（1）-取代类似物的合成与抗胆碱酯酶活性
J Med Chem. 1988 Dec;31(12):2297-300. doi: 10.1021/jm00120a008.
4
Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.基于柳酰苯胺和 4-氯苯酚的 N-单取代氨基甲酸酯类化合物作为乙酰胆碱酯酶和丁酰胆碱酯酶潜在抑制剂的研究。
Bioorg Chem. 2018 Oct;80:668-673. doi: 10.1016/j.bioorg.2018.07.017. Epub 2018 Jul 17.
5
Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.实验性阿尔茨海默病药物苯丝氨酸的甲基类似物：乙酰胆碱酯酶和丁酰胆碱酯酶抑制作用的合成及构效关系
J Med Chem. 2001 Nov 22;44(24):4062-71. doi: 10.1021/jm010080x.
6
In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
J Pharm Pharmacol. 1985 Jan;37(1):42-8. doi: 10.1111/j.2042-7158.1985.tb04928.x.
7
Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.带有氨基甲酸酯部分的环状酰基胍能够对乙酰胆碱酯酶或丁酰胆碱酯酶产生强效且可控的抑制作用。
Bioorg Med Chem. 2014 Sep 1;22(17):5020-34. doi: 10.1016/j.bmc.2014.06.010. Epub 2014 Jun 26.
8
Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.合成毒扁豆碱类似物及其抗胆碱酯酶活性评价。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1532-4. doi: 10.1016/j.bmcl.2010.01.097. Epub 2010 Jan 25.
9
Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.（3aS）-N1，N8-双去甲毒扁豆碱、（3aS）-N1，N8-双去甲毒扁豆胺及其对映异构体以及毒扁豆碱其他潜在代谢产物的合成与抗胆碱酯酶活性
J Med Chem. 1998 Jun 18;41(13):2371-9. doi: 10.1021/jm9800494.
10
Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.
FEBS Lett. 1986 Jun 9;201(2):190-2. doi: 10.1016/0014-5793(86)80606-8.
引用本文的文献
1
Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.阿尔茨海默病治疗与管理的最新进展：精准医学视角。
Curr Top Med Chem. 2024;24(19):1699-1737. doi: 10.2174/0115680266299847240328045737.
2
High-affinity carbamate analogues of morphinan at opioid receptors.吗啡喃在阿片受体处的高亲和力氨基甲酸酯类似物。
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1508-11. doi: 10.1016/j.bmcl.2007.01.013. Epub 2007 Jan 17.
3
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.用于阿尔茨海默病的胆碱酯酶抑制剂的药效学-耐受性关系
CNS Drugs. 2001;15(5):375-90. doi: 10.2165/00023210-200115050-00004.
4
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan.一种解释抗癌药物伊立替康不良胆碱能效应的新机制的表征。
Br J Pharmacol. 2001 Jan;132(1):73-84. doi: 10.1038/sj.bjp.0703766.
5
Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.苯丝氨酸：一种毒扁豆碱衍生物，是一种长效胆碱酯酶抑制剂，在14单元T型迷宫实验中，对减轻东莨菪碱诱导的大鼠学习障碍具有较宽的有效剂量范围。
Psychopharmacology (Berl). 1993;112(4):415-20. doi: 10.1007/BF02244888.
Zotero 插件